Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-02-27

Clinical Trial Update: Role of the Microbiome in Graves' Orbitopathy [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 trial is investigating the role of the microbiome in Graves' orbitopathy, with the current status listed as UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | Conditions: Graves' Disease | Phase 1, Phase 2 | Status: UNKNOWN